Roberts Zachary - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 25, 2024, Roberts Zachary's relationship to Allogene Therapeutics, Inc. (ALLO) is Officer (EVP of R&D), and currently has 515,253 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
Roberts Zachary - Insider Non-Derivative Transactions of ALLO Common Stock
Roberts Zachary - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 26, 2024 | Acquisition -- (Common Stock) | 140000 | 0 | 515253 |
| Jan 23, 2024 | F -- (Common Stock) | 24690 | 3.17 | 375253 |
| Mar 23, 2023 | Acquisition -- (Common Stock) | 148035 | 0 | 399943 |
| Jan 21, 2023 | Acquisition -- (Common Stock) | 251908 | 0 | 251908 |